Vaccine‐Induced Th1‐Type Responses are Dominant over Th2‐Type Responses in the Short Term whereas Pre‐existing Th2 Responses are Dominant in the Longer Term
Open Access
- 1 May 1998
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 47 (5) , 459-465
- https://doi.org/10.1046/j.1365-3083.1998.00327.x
Abstract
The effect of adjuvant on induction of human papillomavirus type 16 E7 protein‐specific cytotoxic T lymphocytes (CTL) and immunoglobulin G (IgG)2a antibody was studied in C57BL/6 J mice immunized wit...Keywords
This publication has 39 references indexed in Scilit:
- Immune deviation: A historical perspective*Immunology & Cell Biology, 1996
- The Current Status of Therapeutic HPV VaccineAnnals of Medicine, 1996
- Comparison of adjuvants for immune potentiating properties and side effects in miceVeterinary Immunology and Immunopathology, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- T-helper epitopes of the E7 transforming protein of cervical cancer associated human papillomavirus type 18 (HPV18)Virus Research, 1995
- Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivoEuropean Journal of Immunology, 1995
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- The adjuvanticity of Algammulin, a new vaccine adjuvantVaccine, 1991
- Th1 And Th2 Cells: Different Patterns Of Lymphokine Secretion Lead To Different Functional PropertiesAnnual Review of Immunology, 1989
- Saponin adjuvantsArchiv für die gesamte Virusforschung, 1974